Lisa Poulos
Psychiatric/Mental Health · Greensboro, NCNPI 1174561740
Payments from drug & device makers
Across 542 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Neurocrine Biosciences, Inc.$1K
- Alkermes, Inc.$1K
- Validus Pharmaceuticals LLC$964
- Lundbeck LLC$535
- Otsuka America Pharmaceutical, Inc.$534
- plus $5K from 27 others
What the payments were for
- Food & beverage$10,31899%
- Education$1361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 119 | $1,463 |
| Neurocrine Biosciences, Inc. | 43 | $1,245 |
| Alkermes, Inc. | 61 | $1,136 |
| Validus Pharmaceuticals LLC | 6 | $964 |
| Lundbeck LLC | 30 | $535 |
| Otsuka America Pharmaceutical, Inc. | 31 | $534 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $502 |
| Johnson & Johnson | 21 | $500 |
| Tris Pharma Inc | 13 | $368 |
| Bausch Health US, LLC | 22 | $309 |
| Indivior Inc. | 16 | $291 |
| Axsome Therapeutics, Inc. | 13 | $282 |
| Corium, LLC | 15 | $280 |
| Teva Pharmaceuticals USA, Inc. | 18 | $278 |
| Sunovion Pharmaceuticals Inc. | 19 | $243 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $243 |
| Vanda Pharmaceuticals Inc. | 13 | $229 |
| Acadia Pharmaceuticals Inc | 12 | $225 |
| Supernus Pharmaceuticals, Inc. | 12 | $143 |
| Merck | 7 | $118 |
| Noven Therapeutics, LLC | 6 | $88 |
| Eisai Inc. | 5 | $81 |
| Almatica Pharma LLC | 4 | $80 |
| E.r. Squibb & Sons, L.L.C. | 3 | $80 |
| Avanir Pharmaceuticals, Inc. | 5 | $66 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Avion Pharmaceuticals | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Biogen | 1 | $21 |
| USWM, LLC | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Equetro$915
- ARISTADA$442
- INGREZZA$358
- SPRAVATO$125
- Quillichew ER$118
- Dyanavel XR$118
- Quillivant$118
- ARISTADA INITIO$111
How this compares
$10,454 in reported general payments places this provider in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 75 | $657,506 |
| Austedo XrDeutetrabenazine | 15 | $153,487 |
| AustedoDeutetrabenazine | 20 | $140,550 |
| RexultiBrexpiprazole | 72 | $95,493 |
| VraylarCariprazine Hcl | 45 | $67,362 |
| Abilify MaintenaAripiprazole | 19 | $60,333 |
| SpravatoEsketamine Hcl | 31 | $38,835 |
| TrintellixVortioxetine Hydrobromide | 66 | $33,361 |
| CaplytaLumateperone Tosylate | 14 | $29,455 |
| Risperdal ConstaRisperidone Microspheres | 12 | $28,283 |
| VyvanseLisdexamfetamine Dimesylate | 47 | $20,358 |
| XanaxAlprazolam | 13 | $12,208 |
| Lisdexamfetamine Dimesylate | 70 | $12,132 |
| SavellaMilnacipran Hcl | 17 | $12,117 |
| SunosiSolriamfetol Hcl | 13 | $10,934 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,245 | $657,50675 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo | $278 | $294,03835 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $534 | $155,82691 claims |
| AbbVieVraylar, Savella | $1,463 | $79,47962 claims |
| Johnson & JohnsonSpravato, Risperdal Consta | $500 | $67,11843 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $243 | $53,719113 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $502 | $29,45514 claims |
| Axsome Therapeutics, Inc.Sunosi | $282 | $10,93413 claims |
| MerckBelsomra | $118 | $8,21319 claims |
| Tris Pharma IncDyanavel Xr | $368 | $6,99115 claims |
| Eisai Inc.Dayvigo | $81 | $3,96312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.
Other psychiatric/mental health in Greensboro
- April NandigamGreensboro$88K
- Brittany MitchellGreensboro$12K
- Marian FriedmanGreensboro$9K
- Brian WhiteGreensboro$8K
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.